Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Cushing’s disease

Rare Disease news

Rare Disease Video Recap—January 29, 2026

This biweekly Rare Disease Video Recap highlights significant regulatory…

Rare Disease news

Rare Disease Today—January 22, 2026

This week's updates focus on significant regulatory approvals, orphan drug…

Endocrinology

Endocrinology Weekly Update - October 7th 2025

Endocrinology Update: Isturisa dosing model, YAP–T1D link, Mounjaro expansion…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: Teva and Blackstone Life Sciences $400m duvakitug financing
Neuroscience Today—March 4, 2026
Immunology Today—March 4, 2026
Women’s Health Video Recap—March 4, 2026
Lucid Diligence Brief: Poplar Therapeutics $95 million Series A

Tags

APDS Bleeding Disorders breast cancer research BRUIN Trial Cardiovascular Research Cellenkos FLEXI FSGS Genitourinary Cancers GIMM platform Global Biosimilar Week Heart attack Henlius Biotech Instituto Butantan KB407 Kisqali LDL Longevity Market Lumos AI marketing strategy MAT2A medical AI MicuRx Multistage malaria vaccine neuroblastoma NSLC Oncology News online patient communities PAPZIMEOS pharma industry trends 2025 platform partnerships Propionic acidemia psoriatic arthritis Ratutrelvir RSV Vaccine Savara Pharmaceuticals SK biosciences sweetener T-cell leukemia Targeted Therapy vapendavir Weight Loss Science Yatiri Bio Yescarta Ziftomenib

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Teva and Blackstone Life Sciences $400m duvakitug financing
Neuroscience Today—March 4, 2026
Immunology Today—March 4, 2026
Women’s Health Video Recap—March 4, 2026
Lucid Diligence Brief: Poplar Therapeutics $95 million Series A

TAGS

APDS Bleeding Disorders breast cancer research BRUIN Trial Cardiovascular Research Cellenkos FLEXI FSGS Genitourinary Cancers GIMM platform Global Biosimilar Week Heart attack Henlius Biotech Instituto Butantan KB407 Kisqali LDL Longevity Market Lumos AI marketing strategy MAT2A medical AI MicuRx Multistage malaria vaccine neuroblastoma NSLC Oncology News online patient communities PAPZIMEOS pharma industry trends 2025 platform partnerships Propionic acidemia psoriatic arthritis Ratutrelvir RSV Vaccine Savara Pharmaceuticals SK biosciences sweetener T-cell leukemia Targeted Therapy vapendavir Weight Loss Science Yatiri Bio Yescarta Ziftomenib

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy